Avoro Capital Advisors LLC - 31 Mar 2025 SCHEDULE 13G/A Report for BIOCRYST PHARMACEUTICALS INC Common Stock, $0.01 par value (BCRX)

Filing Manager
Avoro Capital Advisors LLC
Reporting Manager
Avoro Capital Advisors LLC
Security
BIOCRYST PHARMACEUTICALS INC Common Stock, $0.01 par value
Symbol
BCRX
Shares outstanding
207,142,857 shares
Disclosed Ownership
8,700,000 shares
Ownership
4.2%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 09:31:29 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Avoro Capital Advisors LLC 4.2% 8,700,000 8,700,000 0 /s/ Scott Epstein Scott Epstein, Chief Financial Officer & Chief Compliance Officer
Behzad Aghazadeh 4.2% 8,700,000 8,700,000 0 /s/ Behzad Aghazadeh Behzad Aghazadeh, Individually